9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Nivolumab in Patients With Recurrent Malignant Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Nivolumab in Patients With Recurrent Malignant Mesothelioma

Nivolumab in Patients With Recurrent Malignant Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma

Estimated Enrollment: 33

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: DCR,  PFS,  OS, TTP

Interventions: nivolumab,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: July 2017

Completion Date: July 2017

Last  Posted Date: September 14, 2017

Location:

Website Link: https://ClinicalTrials.gov/show/NCT02497508

Was this article helpful?
Dislike 0